Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: A review of antiplatelet therapy

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Balasubramaniam, Karthik ^a   Viswanathan, Girish N ^a   Marshall, Sally M ^a   Zaman, Azfar G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APIXABAN; ATOPAXAR; BLOOD CLOTTING FACTOR 7; CANGRELOR; CILOSTAZOL; CLOPIDOGREL; DABIGATRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PICOTAMIDE; PLACEBO; PRASUGREL; RIVAROXABAN; SIMVASTATIN; THROMBIN; THROMBOPLASTIN; TICAGRELOR; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG; VORAPAXAR;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE CALCULATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; LOW DRUG DOSE; METABOLIC SYNDROME X; MONOTHERAPY; NEUTROPENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTIMAL DRUG DOSE; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SIDE EFFECT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

EID: 84856609565     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/909154     Document Type: Review

References (220)

1. DeFronzo R. A., International Textbook of Diabetes Mellitus 2004 3rd Chichester, UK John Wiley Sons Wiley Reference Series in Biostatistics
2. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Research and Clinical Practice 2010 87 1 4 14
3. Roglic G., Unwin N., Bennett P. H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H., The burden of mortality attributable to diabetes: realistic estimates for the year 2000 Diabetes Care 2005 28 9 2130 2135 (Pubitemid 41242456)
4. Hopkins P. N., Hunt S. C., Wu L. L., Williams G. H., Williams R. R., Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Current Opinion in Lipidology 1996 7 4 241 253 (Pubitemid 26280234)
5. Gray R. S., Fabsitz R. R., Cowan L. D., Lee E. T., Howard B. V., Savage P. J., Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study American Journal of Epidemiology 1998 148 9 869 878 (Pubitemid 28484106)
6. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories Circulation 1998 97 18 1837 1847 (Pubitemid 28213628)
7. Wilson P. W. F., Diabetes mellitus and coronary heart disease American Journal of Kidney Diseases 1998 32 5, supplement 3 S89 S100
8. McGill H. C. Jr., McMahan C. A., Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group The American Journal of Cardiology 1998 82 10B 30T 36T
9. Haffner S. M., Lehto S., Rnnemaa T., Pyrl K., Laakso M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction The New England Journal of Medicine 1998 339 4 229 234 (Pubitemid 28350165)
10. Laakso M., Hyperglycemia and cardiovascular disease in type 2 diabetes Diabetes 1999 48 5 937 942 (Pubitemid 29226337)
11. Brezinka V., Padmos I., Coronary heart disease risk factors in women European Heart Journal 1994 15 11 1571 1584 (Pubitemid 24350618)
12. Stone P. H., Muller J. E., Hartwell T., York B. J., Rutherford J. D., Parker C. B., Turi Z. G., Strauss H. W., Willerson J. T., Robertson T., Braunwald E., Jaffe A. S., The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group Journal of the American College of Cardiology 1989 14 1 49 57 (Pubitemid 19165535)
13. Singer D. E., Moulton A. W., Nathan D. M., Diabetic myocardial infarction: interaction of diabetes with other preinfarction risk factors Diabetes 1989 38 3 350 357 (Pubitemid 19071476)
14. Smith J. W., Marcus F. I., Serokman R., Prognosis of patients with diabetes mellitus after acute myocardial infarction The American Journal of Cardiology 1984 54 7 718 721 (Pubitemid 14006136)
15. Third report of the National Cholestrol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholestrol in adults (adult treatment panel III) final report Circulation 2002 106 3143 3421
16. Malmberg K., Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group British Medical Journal 1997 314 7093 1512 1515 (Pubitemid 27216066)
17. Gerstein H. C., Miller M. E., Byington R. P., Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine 2008 358 24 2545 2559 (Pubitemid 351831356)
18. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen C. E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., De Galan B. E., Joshi R., Travert F., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes The New England Journal of Medicine 2008 358 24 2560 2572 (Pubitemid 351831357)
19. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P. D., Zieve F. J., Marks J., Davis S. N., Hayward R., Warren S. R., Goldman S., McCarren M., Vitek M. E., Henderson W. G., Huang G. D., Glucose control and vascular complications in veterans with type 2 diabetes The New England Journal of Medicine 2009 360 2 129 139
20. Kip K. E., Faxon D. P., Detre K. M., Yeh W., Kelsey S. F., Currier J. W., Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation 1996 94 8 1818 1825 (Pubitemid 26349292)
21. Stein B., Weintraub W. S., Gebhart S. S. P., Cohen-Bernstein C. L., Grosswald R., Liberman H. A., Douglas J. S. Jr., Morris D. C., King S. B. III, Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty Circulation 1995 91 4 979 989
22. Yusuf S., Zhao F., Mehta S. R., Chrolavicius S., Tognoni G., Fox K. K., Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation The New England Journal of Medicine 2001 345 7 494 502 (Pubitemid 32758501)
23. Mak K.-H., Moliterno D. J., Granger C. B., Miller D. P., White H. D., Wilcox R. G., Califf R. M., Topol E. J., Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Journal of the American College of Cardiology 1997 30 1 171 179
24. Roffi M., Topol E. J., Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes European Heart Journal 2004 25 3 190 198 (Pubitemid 38235154)
25. Flaherty J. D., Davidson C. J., Diabetes and coronary revascularization The Journal of the American Medical Association 2005 293 12 1501 1508 (Pubitemid 40393296)
26. Cola C., Brugaletta S., Yuste V. M., Campos B., Angiolillo D. J., Sabaté M., Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization Vascular Health and Risk Management 2009 5 101 119
27. Creager M. A., Lscher T. F., Cosentino F., Beckman J. A., Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I Circulation 2003 108 12 1527 1532 (Pubitemid 37176462)
28. Widlansky M. E., Gokce N., Keaney J. F. Jr., Vita J. A., The clinical implications of endothelial dysfunction Journal of the American College of Cardiology 2003 42 7 1149 1160 (Pubitemid 37188333)
29. Vita J. A., Keaney J. F. Jr., Endothelial function: a barometer for cardiovascular risk? Circulation 2002 106 6 640 642 (Pubitemid 34851918)
30. Ross R., Atherosclerosisan inflammatory disease The New England Journal of Medicine 1999 340 2 115 126
31. Libby P., Ridker P. M., Maseri A., Inflammation and atherosclerosis Circulation 2002 105 9 1135 1143 (Pubitemid 34212626)
32. Li H., Cybulsky M. I., Gimbrone M. A. Jr., Libby P., An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium Arteriosclerosis Thrombosis 1993 13 2 197 204 (Pubitemid 23056792)
33. Wheatcroft S. B., Williams I. L., Shah A. M., Kearney M. T., Pathophysiological implications of insulin resistance on vascular endothelial function Diabetic Medicine 2003 20 4 255 268 (Pubitemid 36606117)
34. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis Physiological Reviews 2004 84 4 1381 1478 (Pubitemid 39302636)
35. San Martn A., Du P., Dikalova A., Lassgue B., Aleman M., Gngora M. C., Brown K., Joseph G., Harrison D. G., Taylor W. R., Jo H., Griendling K. K., Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes American Journal of Physiology 2007 292 5 H2073 H2082
36. Gao L., Mann G. E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling Cardiovascular Research 2009 82 1 9 20
37. Maloney E., Sweet I. R., Hockenbery D. M., Pham M., Rizzo N. O., Tateya S., Handa P., Schwartz M. W., Kim F., Activation of NF- B by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 9 1370 1375
38. Rajagopalan S., Harrison D. G., Reversing endothelial dysfunction with ACE inhibitors: a new trend Circulation 1996 94 3 240 243 (Pubitemid 26266102)
39. Henriksen E. J., Improvement of insulin sensitivity by antagonism of the renin-angiotensin system American Journal of Physiology 2007 293 3 R974 R980
40. Oak J. H., Cai H., Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice Diabetes 2007 56 1 118 126
41. Beckman J. A., Creager M. A., Libby P., Diabetes and atherosclerosis epidemiology, pathophysiology, and management The Journal of the American Medical Association 2002 287 19 2570 2581 (Pubitemid 34517204)
42. Pieper G. M., Riaz ul H., Activation of nuclear factor- B in cultured endothelial cells by increased glucose concentration: prevention by calphostin C Journal of Cardiovascular Pharmacology 1997 30 4 528 532 (Pubitemid 27527591)
43. Piga R., Naito Y., Kokura S., Handa O., Yoshikawa T., Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells Atherosclerosis 2007 193 2 328 334 (Pubitemid 47058120)
44. Keaney J. F. Jr., Massaro J. M., Larson M. G., Vasan R. S., Wilson P. W. F., Lipinska I., Corey D., Sutherland P., Vita J. A., Benjamin E. J., Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study Journal of the American College of Cardiology 2004 44 1 168 173 (Pubitemid 38968477)
45. Festa A., D'Agostino R. Jr., Howard G., Mykknen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 2000 102 1 42 47 (Pubitemid 30430551)
46. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., Wadden T., Tumor necrosis factor- in sera of obese patients: fall with weight loss The Journal of Clinical Endocrinology Metabolism 1998 83 8 2907 2910 (Pubitemid 28493796)
47. Vozarova B., Weyer C., Hanson K., Tataranni P. A., Bogardus C., Pratley R. E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion Obesity Research 2001 9 7 414 417 (Pubitemid 33603868)
48. Schulze M. B., Rimm E. B., Li T., Rifai N., Stampfer M. J., Hu F. B., C-reactive protein and incident cardiovascular events among men with diabetes Diabetes Care 2004 27 4 889 894 (Pubitemid 38420210)
49. He Z., King G. L., Protein kinase C isoform inhibitors: a new treatment for diabetic cardiovascular diseases Circulation 2004 110 1 7 9 (Pubitemid 38880127)
50. Inoguchi T., Battan R., Handler E., Sportsman J. R., Heath W., King G. L., Preferential elevation of protein kinase C isoform II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 11059 11063
51. Xia P., Inoguchi T., Kern T. S., Engerman R. L., Oates P. J., King G. L., Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia Diabetes 1994 43 9 1122 1129 (Pubitemid 24265474)
52. Tesfamariam B., Brown M. L., Cohen R. A., Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C Journal of Clinical Investigation 1991 87 5 1643 1648
53. Goel A., Zhang Y., Anderson L., Rahimian R., Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C and superoxide but not of Rho kinase Cardiovascular Research 2007 76 2 351 360 (Pubitemid 350198594)
54. Rask-Madsen C., King G. L., Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 487 496 (Pubitemid 40315668)
55. Itani S. I., Ruderman N. B., Schmieder F., Boden G., Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I B- Diabetes 2002 51 7 2005 2011 (Pubitemid 34729001)
56. Beckman J. A., Goldfine A. B., Gordon M. B., Garrett L. A., Creager M. A., Inhibition of protein kinase C prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans Circulation Research 2002 90 1 107 111 (Pubitemid 34074616)
57. Mehta N. N., Sheetz M., Price K., Comiskey L., Amrutia S., Iqbal N., Mohler E. R., Reilly M. P., Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus Cardiovascular Drugs and Therapy 2009 23 1 17 24
58. Lowell B. B., Shulman G. I., Mitochondrial dysfunction and type 2 diabetes Science 2005 307 5708 384 387 (Pubitemid 40139974)
59. Kim J. A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance Circulation Research 2008 102 4 401 414 (Pubitemid 351651099)
60. Zorzano A., Liesa M., Palacn M., Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes International Journal of Biochemistry and Cell Biology 2009 41 10 1846 1854
61. Goldman S., Zhang Y., Jin S., Autophagy and adipogenesis: implications in obesity and type II diabetes Autophagy 2010 6 1 179 181
62. Tabit C. E., Chung W. B., Hamburg N. M., Vita J. A., Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications Reviews in Endocrine and Metabolic Disorders 2010 11 1 61 74
63. Badimon J. J., Zaman A., Helft G., Fayad Z., Fuster V., Acute coronary syndromes: pathophysiology and preventive priorities Thrombosis and Haemostasis 1999 82 2 997 1004
64. Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A., Increased platelet thromboxane synthesis in diabetes mellitus Journal of Laboratory and Clinical Medicine 1981 97 1 87 96 (Pubitemid 11183541)
65. Eibl N., Krugluger W., Streit G., Schrattbauer K., Hopmeier P., Schernthaner G., Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes European Journal of Clinical Investigation 2004 34 3 205 209 (Pubitemid 38406635)
66. Lefkovits J., Plow E. F., Topol E. J., Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine The New England Journal of Medicine 1995 332 23 1553 1559
67. Colwell J. A., Nesto R. W., The platelet in diabetes: focus on prevention of ischemic events Diabetes Care 2003 26 7 2181 2188
68. Ferroni P., Basili S., Falco A., Dav G., Platelet activation in type 2 diabetes mellitus Journal of Thrombosis and Haemostasis 2004 2 8 1282 1291 (Pubitemid 40186123)
69. Li Y., Woo V., Bose R., Platelet hyperactivity and abnormal Ca 2+ homeostasis in diabetes mellitus American Journal of Physiology 2001 280 4 H1480 H1489
70. Gawaz M., Ott I., Reininger A. J., Neumann F. J., Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo Thrombosis and Haemostasis 1994 72 6 912 918
71. Lindemann S., Tolley N. D., Dixon D. A., McIntyre T. M., Prescott S. M., Zimmerman G. A., Weyrich A. S., Activated platelets mediate inflammatory signaling by regulated interleukin 1 synthesis Journal of Cell Biology 2001 154 3 485 490 (Pubitemid 34286155)
72. Cipollone F., Mezzetti A., Porreca E., Di Febbo C., Nutini M., Fazia M., Falco A., Cuccurullo F., Dav G., Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy Circulation 2002 106 4 399 402 (Pubitemid 34803680)
73. Weyrich A. S., Lindemann S., Zimmerman G. A., The evolving role of platelets in inflammation Journal of Thrombosis and Haemostasis 2003 1 9 1897 1905
74. Ferreiro J. L., Angiolillo D. J., Diabetes and antiplatelet therapy in acute coronary syndrome Circulation 2011 123 7 798 813
75. Burnier L., Fontana P., Kwak B. R., Angelillo-Scherrer A., Cell-derived microparticles in haemostasis and vascular medicine Thrombosis and Haemostasis 2009 101 3 439 451
76. Morel O., Kessler L., Ohlmann P., Bareiss P., Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis Atherosclerosis 2010 212 2 367 376
77. George F. D., Microparticles in vascular diseases Thrombosis Research 2008 122 supplement 1 S55 S59
78. Morel O., Morel N., Freyssinet J. M., Toti F., Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses Platelets 2008 19 1 9 23 (Pubitemid 351171554)
79. Schwertz H., Tolley N. D., Foulks J. M., Denis M. M., Risenmay B. W., Buerke M., Tilley R. E., Rondina M. T., Harris E. M., Kraiss L. W., Mackman N., Zimmerman G. A., Weyrich A. S., Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets Journal of Experimental Medicine 2006 203 11 2433 2440 (Pubitemid 44664613)
80. Leroyer A. S., Tedgui A., Boulanger C. M., Role of microparticles in atherothrombosis Journal of Internal Medicine 2008 263 5 528 537 (Pubitemid 351533557)
81. Ardoin S. P., Shanahan J. C., Pisetsky D. S., The role of microparticles in inflammation and thrombosis Scandinavian Journal of Immunology 2007 66 2-3 159 165 (Pubitemid 47063209)
82. Nomura S., Suzuki M., Katsura K., Xie G. L., Miyazaki Y., Miyake T., Kido H., Kagawa H., Fukuhara S., Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus Atherosclerosis 1995 116 2 235 240
83. Diamant M., Nieuwland R., Pablo R. F., Sturk A., Smit J. W. A., Radder J. K., Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus Circulation 2002 106 19 2442 2447 (Pubitemid 35278799)
84. Ueba T., Haze T., Sugiyama M., Higuchi M., Asayama H., Karitani Y., Nishikawa T., Yamashita K., Nagami S., Nakayama T., Kanatani K., Nomura S., Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome Thrombosis and Haemostasis 2008 100 2 280 285
85. Omoto S., Nomura S., Shouzu A., Nishikawa M., Fukuhara S., Iwasaka T., Detection of monocyte-derived microparticles in patients with type II diabetes mellitus Diabetologia 2002 45 4 550 555 (Pubitemid 34533834)
86. Nomura S., Shouzu A., Omoto S., Nishikawa M., Iwasaka T., Fukuhara S., Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes Clinical and Applied Thrombosis/Hemostasis 2004 10 3 205 215 (Pubitemid 38982044)
87. Bernard S., Loffroy R., Sérusclat A., Boussel L., Bonnefoy E., Thévenon C., Rabilloud M., Revel D., Moulin P., Douek P., Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT) Atherosclerosis 2009 203 2 429 435
88. Morel O., Pereira B., Averous G., Faure A., Jesel L., Germain P., Grunebaum L., Ohlmann P., Freyssinet J. M., Bareiss P., Toti F., Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation Atherosclerosis 2009 204 2 636 641
89. Gerrits A. J., Koekman C. A., Yildirim C., Nieuwland R., Akkerman J. W. N., Insulin inhibits tissue factor expression in monocytes Journal of Thrombosis and Haemostasis 2009 7 1 198 205
90. Sommeijer D. W., Joop K., Leyte A., Reitsma P. H., Ten Cate H., Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes Journal of Thrombosis and Haemostasis 2005 3 6 1168 1171 (Pubitemid 41725237)
91. Nomura S., Inami N., Shouzu A., Omoto S., Kimura Y., Takahashi N., Tanaka A., Urase F., Maeda Y., Ohtani H., Iwasaka T., The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients Platelets 2009 20 1 16 22
92. Koh K. K., Quon M. J., Han S. H., Ahn J. Y., Lee Y., Shin E. K., Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes Atherosclerosis 2007 194 1 230 237 (Pubitemid 47464302)
93. Diamant M., Tushuizen M. E., Abid-Hussein M. N., Hau C. M., Bing A. N., Sturk A., Nieuwland R., Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent Thrombosis and Haemostasis 2008 100 3 489 497
94. Vandendries E. R., Furie B. C., Furie B., Role of P-selectin and PSGL-I in coagulation and thrombosis Thrombosis and Haemostasis 2004 92 3 459 466 (Pubitemid 39248002)
95. Rinder H. M., Bonan J. L., Rinder C. S., Ault K. A., Smith B. R., Activated and unactivated platelet adhesion to monocytes and neutrophils Blood 1991 78 7 1760 1769
96. Hidari K. I., Weyrich A. S., Zimmerman G. A., McEver R. P., Engagement of P-selectin glycoprotein ligand, 1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils Journal of Biological Chemistry 1997 272 45 28750 28756 (Pubitemid 27517833)
97. Elalamy I., Chakroun T., Gerotziafas G. T., Petropoulou A., Robert F., Karroum A., Elgrably F., Samama M. M., Hatmi M., Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients Thrombosis Research 2008 121 6 843 848 (Pubitemid 351506449)
98. Hu H., Li N., Yngen M., stenson C.-G., Wallén N. H., Hjemdahl P., Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus: relationship to microangiopathy Journal of Thrombosis and Haemostasis 2004 2 1 58 64 (Pubitemid 40185620)
99. Alzahrani S. H., Ajjan R. A., Coagulation and fibrinolysis in diabetes Diabetes and Vascular Disease Research 2010 7 4 260 273
100. Breitenstein A., Tanner F. C., Lscher T. F., Tissue factor and cardiovascular disease: quo vadis? Circulation 2010 74 1 3 12
101. Annex B. H., Denning S. M., Channon K. M., Sketch M. H. Jr., Stack R. S., Morrissey J. H., Peters K. G., Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes Circulation 1995 91 3 619 622
102. Suefuji H., Ogawa H., Yasue H., Kaikita K., Soejima H., Motoyama T., Mizuno Y., Oshima S., Saito T., Tsuji I., Kumeda K., Kamikubo Y., Nakamura S., Increased plasma tissue factor levels in acute myocardial infarction American Heart Journal 1997 134 2, part 1 253 259 (Pubitemid 27406688)
103. Soejima H., Ogawa H., Yasue H., Kaikita K., Nishiyama K., Misumi K., Takazoe K., Miyao Y., Yoshimura M., Kugiyama K., Nakamura S., Tsuji I., Kumeda K., Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina Circulation 1999 99 22 2908 2913 (Pubitemid 29258979)
104. Boden G., Vaidyula V. R., Homko C., Cheung P., Rao A. K., Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose The Journal of Clinical Endocrinology Metabolism 2007 92 11 4352 4358 (Pubitemid 350074756)
105. Heinrich J., Balleisen L., Schulte H., Assmann G., van de Loo J., Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men Arteriosclerosis Thrombosis 1994 14 1 54 59
106. Folsom A. R., Wu K. K., Davis C. E., Conlan M. G., Sorlie P. D., Szklo M., Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors Atherosclerosis 1991 91 3 191 205
107. Scarabin P.-Y., Aillaud M.-F., Amouyel P., Evans A., Luc G., Ferrires J., Arveiler D., Juhan-Vague I., Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarctionthe PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thrombosis and Haemostasis 1998 80 5 749 756 (Pubitemid 28521717)
108. Heywood D. M., Mansfield M. W., Grant P. J., Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus Thrombosis and Haemostasis 1996 75 3 401 406 (Pubitemid 26099702)
109. Karatela R. A., Sainani G. S., Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2) Diabetes Research and Clinical Practice 2009 84 3 e41 e44
110. Wolberg A. S., Campbell R. A., Thrombin generation, fibrin clot formation and hemostasis Transfusion and Apheresis Science 2008 38 1 15 23
111. Ceriello A., Esposito K., Ihnat M., Zhang J., Giugliano D., Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes Journal of Thrombosis and Haemostasis 2009 7 7 1228 1230
112. Corrado E., Rizzo M., Coppola G., Fattouch K., Novo G., Marturana I., Ferrara F., Novo S., An update on the role of markers of inflammation in atherosclerosis Journal of Atherosclerosis and Thrombosis 2010 17 1 1 11
113. Guardado-Mendoza R., Jimenez-Ceja L., Pacheco-Carrasco M. F., Aguayo-Godinez A., Molina-Padilla J., Villa-Godinez G., Aleman-Mireles A., Escobedo-De La Pea J., Majluf-Cruz A., Fibrinogen is associated with silent myocardial ischaemia in type 2 diabetes mellitus Acta Cardiologica 2009 64 4 523 530
114. Ajjan R., Grant P. J., Coagulation and atherothrombotic disease Atherosclerosis 2006 186 2 240 259
115. Barazzoni R., Kiwanuka E., Zanetti M., Cristini M., Vettore M., Tessari P., Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes Diabetes 2003 52 7 1851 1856 (Pubitemid 36792478)
116. Tessari P., Kiwanuka E., Millioni R., Vettore M., Puricelli L., Zanetti M., Gucciardi A., Tosolini M., Cogo P., Carnielli V., Tiengo A., Barazzoni R., Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria Diabetes Care 2006 29 2 323 328 (Pubitemid 44106512)
117. Seljeflot I., Larseb J. R., Dahl-Jrgensen K., Hanssen K. F., Arnesen H., Fibrinolytic activity is highly influenced by long-term glycemic control in type 1 diabetic patients Journal of Thrombosis and Haemostasis 2006 4 3 686 688
118. Stegenga M. E., van der Crabben S. N., Dessing M. C., Pater J. M., van den Pangaart P. S., De Vos A. F., Tanck M. W., Roos D., Sauerwein H. P., van der Poll T., Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans Diabetic Medicine 2008 25 2 157 164 (Pubitemid 351293406)
119. Alessi M.-C., Juhan-Vague I., Metabolic syndrome, haemostasis and thrombosis Thrombosis and Haemostasis 2008 99 6 995 1000 (Pubitemid 351810479)
120. Dunn E. J., Arins R. A. S., Grant P. J., The influence of type 2 diabetes on fibrin structure and function Diabetologia 2005 48 6 1198 1206 (Pubitemid 40909657)
121. Natarajan A., Zaman A. G., Badimon J. J., Marshall S. M., Platelet-dependent thrombosis in patients with type 2 diabetes and coronary artery disease Diabetes 2007 56
122. Natarajan A., Marshall S. M., Worthley S. G., Badimon J. J., Zaman A. G., The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus Journal of Thrombosis and Haemostasis 2008 6 12 2210 2213
123. Osende J. I., Badimon J. J., Fuster V., Herson P., Rabito P., Vidhun R., Zaman A., Rodriguez O. J., Lev E. I., Rauch U., Heflt G., Fallon J. T., Crandall J. P., Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control Journal of the American College of Cardiology 2001 38 5 1307 1312 (Pubitemid 33033003)
124. Viswanathan G. N., Natarajan A., Marshall S. M., Badimon J. J., Zaman A. G., Higher thrombus burden and impaired clot kinetics in patients with type 2 diabetes mellitus following non St-elevation acute coronary syndrome Circulation 2010 122
125. Viswanathan G. N., Zaman A. G., Marshall S. M., Thrombus burden, clot kinetics and response to anti-platelet therapy in type 2 diabetes Diabetic Medicine 2011 28 supplement 1 1 2
126. Anderson J. L., Adams C. D., Antman E. M., Bridges C. R., Califf R. M., Casey D. E. Jr., Chavey W. E. II, Fesmire F. M., Hochman J. S., Levin T. N., Lincoff A. M., Peterson E. D., Theroux P., Wenger N. K., Wright R. S., Smith Jr. S. C. Jr., Jacobs A. K., Halperin J. L., Hunt S. A., Krumholz H. M., Kushner F. G., Lytle B. W., Nishimura R., Ornato J. P., Page R. L., Riegel B., ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 2007 116 7 e148 e304
127. Antman E. M., Anbe D. T., Armstrong P. W., Bates E. R., Green L. A., Hand M., Hochman J. S., Krumholz H. M., Kushner F. G., Lamas G. A., Mullany C. J., Ornato J. P., Pearle D. L., Sloan M. A., ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) Circulation 2004 110 5 588 636 (Pubitemid 39036178)
128. Schafer A. I., Antiplatelet therapy American Journal of Medicine 1996 101 199 209 (Pubitemid 26296782)
129. Ogawa H., Nakayama M., Morimoto T., Uemura S., Kanauchi M., Doi N., Jinnouchi H., Sugiyama S., Saito Y., Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial The Journal of the American Medical Association 2008 300 18 2134 2141
130. De Berardis G., Sacco M., Strippoli G. F., Pellegrini F., Graziano G., Tognoni G., Nicolucci A., Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials British Medical Journal 2009 339
131. Baigent C., Blackwell L., Collins R., Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials The Lancet 2009 373 9678 1849 1860
132. Patrono C., Garca Rodrguez L. A., Landolfi R., Baigent C., Low-dose aspirin for the prevention of atherothrombosis The New England Journal of Medicine 2005 353 22 2373 2383 (Pubitemid 41713749)
133. Colwell J. A., Aspirin therapy in diabetes Diabetes Care 2004 27 supplement 1 S72 S73
134. King S. B. III, Smith S. C. Jr., Hirshfeld J. W. Jr., Jacobs A. K., Morrison D. A., Williams D. O., Feldman T. E., Kern M. J., O'Neill W. W., Schaff H. V., Whitlow P. L., Adams C. D., Anderson J. L., Buller C. E., Creager M. A., Ettinger S. M., Halperin J. L., Hunt S. A., Krumholz H. M., Kushner F. G., Lytle B. W., Nishimura R., Page R. L., Riegel B., Tarkington L. G., 2007 Focused
135. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group The Lancet 1990 336 8719 827 830
136. Theroux P., Ouimet H., McCans J., Latour J. G., Joly P., Levy G., Pelletier E., Juneau M., Stasiak J., DeGuise P., Pelletier G. B., Rinzler D., Waters D. D., Aspirin, heparin, or both to treat acute unstable angina The New England Journal of Medicine 1988 319 17 1105 1111
137. Lewis H. D. Jr., Davis J. W., Archibald D. G., Protective effects of aspirin against acute myocardial infarction and death in mean with unstable angina. Results of a Veterans Administration Cooperative Study The New England Journal of Medicine 1983 309 7 396 403 (Pubitemid 13033964)
138. Roux S., Christeller S., Ludin E., Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis Journal of the American College of Cardiology 1992 19 3 671 677
139. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group The Lancet 1988 2 8607 349 360
140. Senior K., Aspirin withdrawal increases risk of heart problems The Lancet 2003 362 9395 1558
141. Collaborative overview of randomised trials of antiplatelet therapyI: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration British Medical Journal 1994 308 6921 81 106
142. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients British Medical Journal 2002 324 7329 71 86
143. Mehta S. R., Bassand J. P., Chrolavicius S., Diaz R., Eikelboom J. W., Fox K. A. A., Granger C. B., Jolly S., Joyner C. D., Rupprecht H. J., Widimsky P., Afzal R., Pogue J., Yusuf S., Dose comparisons of clopidogrel and aspirin in acute coronary syndromes The New England Journal of Medicine 2010 363 10 930 942
144. Mehta S. R., Tanguay J. F., Eikelboom J. W., Jolly S. S., Joyner C. D., Granger C. B., Faxon D. P., Rupprecht H. J., Budaj A., Avezum A., Widimsky P., Steg P. G., Bassand J. P., Montalescot G., MacAya C., Di Pasquale G., Niemela K., Ajani A. E., White H. D., Chrolavicius S., Gao P., Fox K. A., Yusuf S., Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial The Lancet 2010 376 9748 1233 1243
145. Storey R. F., Newby L. J., Heptinstall S., Effects of P2Y 1 and P2Y 12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood Platelets 2001 12 7 443 447 (Pubitemid 33097240)
146. Gachet C., ADP receptors of platelets and their inhibition Journal of Thrombosis and Haemostasis 2001 86 1 222 232 (Pubitemid 32663953)
147. Schomig A., Neumann F. J., Kastrati A., A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents The New England Journal of Medicine 1996 334 17 1084 1089 (Pubitemid 26120185)
148. Leon M. B., Baim D. S., Popma J. J., A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators The New England Journal of Medicine 1998 339 23 1665 1671 (Pubitemid 28550691)
149. Bertrand M. E., Legrand V., Boland J., Fleck E., Bonnier J., Emmanuelson H., Vrolix M., Missault L., Chierchia S., Casaccia M., Niccoli L., Oto A., White C., Webb-Peploe M., van Belle E., McFadden E. P., Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study Circulation 1998 98 16 1597 1603 (Pubitemid 28500380)
150. Urban P., Macaya C., Rupprecht H. J., Kiemeneij F., Emanuelsson H., Fontanelli A., Pieper M., Wesseling T., Sagnard L., Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS) Circulation 1998 98 20 2126 2132 (Pubitemid 28527471)
151. Bertrand M. E., Rupprecht H. J., Urban P., Gershlick A. H., Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS) Circulation 2000 102 6 624 629 (Pubitemid 30640661)
152. Cadroy Y., Bossavy J. P., Thalamas C., Sagnard L., Sakariassen K., Boneu B., Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans Circulation 2000 101 24 2823 2828 (Pubitemid 30396013)
153. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee The Lancet 1996 348 9038 1329 1339
154. Bhatt D. L., Marso S. P., Hirsch A. T., Ringleb P. A., Hacke W., Topol E. J., Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus The American Journal of Cardiology 2002 90 6 625 628 (Pubitemid 35264538)
155. Sabatine M. S., Cannon C. P., Gibson C. M., Lpez-Sendn J. L., Montalescot G., Theroux P., Lewis B. S., Murphy S. A., McCabe C. H., Braunwald E., Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study The Journal of the American Medical Association 2005 294 10 1224 1232 (Pubitemid 41352110)
156. Sabatine M. S., Cannon C. P., Gibson C. M., Lpez-Sendn J. L., Montalescot G., Theroux P., Claeys M. J., Cools F., Hill K. A., Skene A. M., McCabe C. H., Braunwald E., Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation The New England Journal of Medicine 2005 352 12 1179 1189 (Pubitemid 40397259)
157. Chen Z., Jiang L., Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial The Lancet 2005 366 9497 1607 1621 (Pubitemid 41552416)
158. Steinhubl S. R., Berger P. B., Mann J. T. III, Fry E. T. A., DeLago A., Wilmer C., Topol E. J., Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial The Journal of the American Medical Association 2002 288 19 2411 2420 (Pubitemid 35340537)
159. Mehta S. R., Yusuf S., Peters R. J. G., Bertrand M. E., Lewis B. S., Natarajan M. K., Malmberg K., Rupprecht H. J., Zhao F., Chrolavicius S., Copland I., Fox K. A. A., Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study The Lancet 2001 358 9281 527 533 (Pubitemid 32772726)
160. Bhatt D. L., Fox K. A. A., Hacke W., Berger P. B., Black H. R., Boden W. E., Cacoub P., Cohen E. A., Creager M. A., Easton J. D., Flather M. D., Haffner S. M., Hamm C. W., Hankey G. J., Johnston S. C., Mak K. H., Mas J. L., Montalescot G., Pearson T. A., Steg P. G., Steinhubl S. R., Weber M. A., Brennan D. M., Fabry-Ribaudo L., Booth J., Topol E. J., Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events The New England Journal of Medicine 2006 354 16 1706 1717
161. Angiolillo D. J., Capranzano P., Pharmacology of emerging novel platelet inhibitors American Heart Journal 2008 156 2, supplement 10S 15S (Pubitemid 352020407)
162. Wiviott S. D., Trenk D., Frelinger A. L., O'Donoghue M., Neumann F. J., Michelson A. D., Angiolillo D. J., Hod H., Montalescot G., Miller D. L., Jakubowski J. A., Cairns R., Murphy S. A., McCabe C. H., Antman E. M., Braunwald E., Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial Circulation 2007 116 25 2923 2932 (Pubitemid 350291199)
163. Wiviott S. D., Braunwald E., McCabe C. H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F. J., Ardissino D., De Servi S., Murphy S. A., Riesmeyer J., Weerakkody G., Gibson C. M., Antman E. M., Prasugrel versus clopidogrel in patients with acute coronary syndromes The New England Journal of Medicine 2007 357 20 2001 2015 (Pubitemid 350106708)
164. Wiviott S. D., Braunwald E., McCabe C. H., Horvath I., Keltai M., Herrman J. P. R., van de Werf F., Downey W. E., Scirica B. M., Murphy S. A., Antman E. M., Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial The Lancet 2008 371 9621 1353 1363
165. Wiviott S. D., Braunwald E., Angiolillo D. J., Meisel S., Dalby A. J., Verheugt F. W. A., Goodman S. G., Corbalan R., Purdy D. A., Murphy S. A., McCabe C. H., Antman E. M., Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 Circulation 2008 118 16 1626 1636
166. Angiolillo D. J., Badimon J. J., Saucedo J. F., Frelinger A. L., Michelson A. D., Jakubowski J. A., Zhu B., Ojeh C. K., Baker B. A., Effron M. B., A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy in diabetes MellitUS (OPTIMUS)-3 Trial European Heart Journal 2011 32 7 838 846
167. Angiolillo D. J., Shoemaker S. B., Desai B., Yuan H., Charlton R. K., Bernardo E., Zenni M. M., Guzman L. A., Bass T. A., Costa M. A., Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study Circulation 2007 115 6 708 716 (Pubitemid 46294761)
168. Angiolillo D. J., Capranzano P., Goto S., Aslam M., Desai B., Charlton R. K., Suzuki Y., Box L. C., Shoemaker S. B., Zenni M. M., Guzman L. A., Bass T. A., A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study European Heart Journal 2008 29 18 2202 2211
169. Storey R. F., Husted S., Harrington R. A., Heptinstall S., Wilcox R. G., Peters G., Wickens M., Emanuelsson H., Gurbel P., Grande P., Cannon C. P., Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y 12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes Journal of the American College of Cardiology 2007 50 19 1852 1856 (Pubitemid 350017792)
170. Wallentin L., Becker R. C., Budaj A., Ticagrelor versus clopidogrel in patients with acute coronary syndromes The New England Journal of Medicine 2009 361 11 1045 1057
171. James S., Angiolillo D. J., Cornel J. H., Erlinge D., Husted S., Kontny F., Maya J., Nicolau J. C., Spinar J., Storey R. F., Stevens S. R., Wallentin L., Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial European Heart Journal 2010 31 24 3006 3016
172. Roffi M., Chew D. P., Mukherjee D., Bhatt D. L., White J. A., Heeschen C., Hamm C. W., Moliterno D. J., Califf R. M., White H. D., Kleiman N. S., Théroux P., Topol E. J., Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes Circulation 2001 104 23 2767 2771 (Pubitemid 33126648)
173. Mehilli J., Kastrati A., Schuhlen H., Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Circulation 2004 110 24 3627 3635 (Pubitemid 40003783)
174. Kastrati A., Mehilli J., Neumann F. J., Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial The Journal of the American Medical Association 2006 295 13 1531 1538
175. De Luca G., Navarese E., Marino P., Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials European Heart Journal 2009 30 22 2705 2713
176. Rao S. V., Eikelboom J. A., Granger C. B., Harrington R. A., Califf R. M., Bassand J. P., Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes European Heart Journal 2007 28 10 1193 1204 (Pubitemid 47343833)
177. Eikelboom J. W., Mehta S. R., Anand S. S., Xie C., Fox K. A. A., Yusuf S., Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 2006 114 8 774 782 (Pubitemid 44268228)
178. Stone G. W., McLaurin B. T., Cox D. A., Bertrand M. E., Lincoff A. M., Moses J. W., White H. D., Pocock S. J., Ware J. H., Feit F., Colombo A., Aylward P. E., Cequier A. R., Darius H., Desmet W., Ebrahimi R., Hamon M., Rasmussen L. H., Rupprecht H. J., Hoekstra J., Mehran R., Ohman E. M., Bivalirudin for patients with acute coronary syndromes The New England Journal of Medicine 2006 355 21 2203 2216 (Pubitemid 44791162)
179. Manoukian S. V., Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction The American Journal of Cardiology 2009 104 5, supplement 9C 15C
180. Angiolillo D. J., Variability in responsiveness to oral antiplatelet therapy The American Journal of Cardiology 2009 103 3, supplement 27A 34A
181. Snoep J. D., Hovens M. M. C., Eikenboom J. C. J., van der Bom J. G., Huisman M. V., Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis Archives of Internal Medicine 2007 167 15 1593 1599 (Pubitemid 47280339)
182. Krasopoulos G., Brister S. J., Beattie W. S., Buchanan M. R., Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis British Medical Journal 2008 336 7637 195 198 (Pubitemid 351212675)
183. Michelson A. D., Cattaneo M., Eikelboom J. W., Aspirin resistance: position paper of the Working Group on Aspirin Resistance Journal of Thrombosis and Haemostasis 2005 3 6 1309 1311 (Pubitemid 41725257)
184. Angiolillo D. J., Fernandez-Ortiz A., Bernardo E., Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment Diabetes 2005 54 8 2430 2435 (Pubitemid 41134272)
185. Angiolillo D. J., Fernandez-Ortiz A., Bernardo E., Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention The American Journal of Cardiology 2006 97 1 38 43 (Pubitemid 41828120)
186. Frelinger A. L. III, Furman M. I., Linden M. D., Li Y., Fox M. L., Barnard M. R., Michelson A. D., Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance Circulation 2006 113 25 2888 2896 (Pubitemid 44297229)
187. Watala C., Pluta J., Golanski J., Rozalski M., Czyz M., Trojanowski Z., Drzewoski J., Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin Journal of Molecular Medicine 2005 83 2 148 158 (Pubitemid 40379303)
188. Davi G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., Patrono C., Thromboxane biosynthesis and platelet function in type II diabetes mellitus The New England Journal of Medicine 1990 322 25 1769 1774 (Pubitemid 20194655)
189. Angiolillo D. J., Fernandez-Ortiz A., Bernardo E., Alfonso F., Macaya C., Bass T. A., Costa M. A., Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives Journal of the American College of Cardiology 2007 49 14 1505 1516 (Pubitemid 46517957)
190. Ferreiro J. L., Angiolillo D. J., Clopidogrel response variability: current status and future directions Journal of Thrombosis and Haemostasis 2009 102 1 7 14
191. Geisler T., Anders N., Paterok M., Langer H., Stellos K., Lindemann S., Herdeg C., May A. E., Gawaz M., Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation Diabetes Care 2007 30 2 372 374 (Pubitemid 46198349)
192. Serebruany V., Pokov I., Kuliczkowski W., Chesebro J., Badimon J., Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease Thrombosis and Haemostasis 2008 100 1 76 82 (Pubitemid 351948748)
193. Angiolillo D. J., Bernardo E., Ramirez C., Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment Journal of the American College of Cardiology 2006 48 2 298 304 (Pubitemid 44026661)
194. Angiolillo D. J., Bernardo E., Capodanno D., Vivas D., Sabaté M., Ferreiro J. L., Ueno M., Jimenez-Quevedo P., Alfonso F., Bass T. A., Macaya C., Fernandez-Ortiz A., Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy Journal of the American College of Cardiology 2010 55 11 1139 1146
195. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G. M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., Colombo A., Incidence, predictors and outcome of thrombosis after succesful implantation of drug-eluting stents The Journal of the American Medical Association 2005 293 17 2126 2130 (Pubitemid 40617065)
196. Urban P., Gershlick A. H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J. E., Wijns W., Berge C., Deme M., Stoll H. P., Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry Circulation 2006 113 11 1434 1441 (Pubitemid 43739440)
197. Kuchulakanti P. K., Chu W. W., Torguson R., Ohlmann P., Rha S. W., Clavijo L. C., Kim S. W., Bui A., Gevorkian N., Xue Z., Smith K., Fournadjieva J., Suddath W. O., Satler L. F., Pichard A. D., Kent K. M., Waksman R., Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents Circulation 2006 113 8 1108 1113
198. Price M. J., Berger P. B., Teirstein P. S., Tanguay J.-F., Angiolillo D. J., Spriggs D., Puri S., Robbins M., Garratt K. N., Bertrand O. F., Stillablower M. E., Aragon J. R., Kandzari D. E., Stinis C. T., Lee M. S., Manoukian S. V., Cannon C. P., Schork N. J., Topol E. J., Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial The Journal of the American Medical Association 2011 305 11 1097 1105
199. Angiolillo D. J., Roffi M., Fernandez-Ortiz A., Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus Expert Review of Cardiovascular Therapy 2011 9 6 697 710
200. Neri Serneri G. G., Coccheri S., Marubini E., Violi F., Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study European Heart Journal 2004 25 20 1845 1852 (Pubitemid 39330236)
201. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT) Circulation 1994 89 2 588 595
202. Gresele P., Migliacci R., Procacci A., De Monte P., Bonizzoni E., Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication Thrombosis and Haemostasis 2007 97 3 444 450 (Pubitemid 46437807)
203. Kariyazono H., Nakamura K., Arima J., Ayukawa O., Onimaru S., Masuda H., Iguro Y., Majima H. J., Sakata R., Yamada K., Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood Blood Coagulation and Fibrinolysis 2004 15 2 157 167 (Pubitemid 38392368)
204. Chamorro A., TP receptor antagonism: a new concept in atherothrombosis and stroke prevention Cerebrovascular Diseases 2009 27 supplement 3 20 27
205. Angiolillo D. J., Guzman L. A., Clinical overview of promising nonthienopyridine antiplatelet agents American Heart Journal 2008 156 2, supplement S23 S28
206. Storey R. F., Wilcox R. G., Heptinstall S., Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease Platelets 2002 13 7 407 413 (Pubitemid 35346941)
207. Harrington R. A., Stone G. W., McNulty S., White H. D., Lincoff A. M., Gibson C. M., Pollack C. V. Jr., Montalescot G., Mahaffey K. W., Kleiman N. S., Goodman S. G., Amine M., Angiolillo D. J., Becker R. C., Chew D. P., French W. J., Leisch F., Parikh K. H., Skerjanec S., Bhatt D. L., Platelet inhibition with cangrelor in patients undergoing PCI The New England Journal of Medicine 2009 361 24 2318 2329
208. Bhatt D. L., Lincoff A. M., Gibson C. M., Stone G. W., McNulty S., Montalescot G., Kleiman N. S., Goodman S. G., White H. D., Mahaffey K. W., Pollack C. V., Manoukian S. V., Widimsky P., Chew D. P., Cura F., Manukov I., Tousek F., Jafar M. Z., Arneja J., Skerjanec S., Harrington R. A., Intravenous platelet blockade with cangrelor during PCI The New England Journal of Medicine 2009 361 24 2330 2341
209. Lee S. W., Park S. W., Hong M. K., Kim Y. H., Lee B. K., Song J. M., Han K. H., Lee C. W., Kang D. H., Song J. K., Kim J. J., Park S. J., Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis Journal of the American College of Cardiology 2005 46 10 1833 1837 (Pubitemid 41579804)
210. Lee S. W., Park S. W., Kim Y. H., Yun S. C., Park D. W., Lee C. W., Hong M. K., Kim H. S., Ko J. K., Park J. H., Lee J. H., Choi S. W., Seong I. W., Cho Y. H., Lee N. H., Kim J. H., Chun K. J., Park S. J., Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) Journal of the American College of Cardiology 2008 51 12 1181 1187 (Pubitemid 351382092)
211. Biondi-Zoccai G. G. L., Lotrionte M., Anselmino M., Moretti C., Agostoni P., Testa L., Abbate A., Cosgrave J., Laudito A., Trevi G. P., Sheiban I., Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention American Heart Journal 2008 155 6 1081 1089
212. Han Y., Li Y., Wang S., Jing Q., Wang Z., Wang D., Shu Q., Tang X., Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study American Heart Journal 2009 157 4 733 739
213. Angiolillo D. J., Capodanno D., Goto S., Platelet thrombin receptor antagonism and atherothrombosis European Heart Journal 2010 31 1 17 28
214. Becker R. C., Moliterno D. J., Jennings L. K., Pieper K. S., Pei J., Niederman A., Ziada K. M., Berman G., Strony J., Joseph D., Mahaffey K. W., van de Werf F., Veltri E., Harrington R. A., Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study The Lancet 2009 373 9667 919 928
215. Goto S., Ogawa H., Takeuchi M., Flather M. D., Bhatt D. L., Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease European Heart Journal 2010 31 21 2601 2613
216. Wittkowsky A. K., New oral anticoagulants: a practical guide for clinicians Journal of Thrombosis and Thrombolysis 2010 29 2 182 191
217. Connolly S. J., Ezekowitz M. D., Yusuf S., Eikelboom J., Oldgren J., Parekh A., Pogue J., Reilly P. A., Themeles E., Varrone J., Wang S., Alings M., Xavier D., Zhu J., Diaz R., Lewis B. S., Darius H., Diener H. C., Joyner C. D., Wallentin L., Alings A. M. W., Amerena J. V., Avezum A., Baumgartner I., Brugada J., Budaj A., Caicedo V., Ceremuzynski L., Chen J. H., Commerford P. J., Connolly S. J., Dans A. L., Darius H., Di Pasquale G., Diaz R., Erol C., Ezekowitz M. D., Ferreira J., Flaker G. C., Flather M. D., Franzosi M. G., Gamboa R., Golitsyn S. P., Gonzalez Hermosillo J. A., Halon D., Heidbuchel H., Hohnloser S. H., Hori M., Huber K., Jansky P., Kamensky G., Keltai M., Kim S., Lau C. P., Le Heuzey J. Y. F., Lewis B. S., Liu L. S., Nanas J., Oldgren J., Pais P. S., Parkhomenko A. N., Pedersen K. E., Piegas L. S., Raev D., Razali O., Simmers T. A., Smith P. J., Talajic M., Tan R. S., Tanomsup S., Toivonen L., Vinereanu D., Wallentin L., Xavier D., Yusuf S., Zhu J., Dabigatran versus warfarin in patients with atrial fibrillation The New England Journal of Medicine 2009 361 12 1139 1151
218. Lonn E., Yusuf S., Hoogwerf B., Pogue J., Yi Q., Zinman B., Bosch J., Dagenais G., Mann J. F. E., Gerstein H. C., Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy Diabetes Care 2002 25 11 1919 1927 (Pubitemid 41071045)
219. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial The Lancet 2002 360 9326 23 33
220. Mnzel T., Keaney J. F. Jr., Are ACE inhibitors a magic bullet against oxidative stress? Circulation 2001 104 13 1571 1574